baber/WOPTO huggingface dataset:
Patent EP-0650590-B1 (EP)
Inventor: KELLN NORMAN
IPC: G01N35/00
Filed: 1993-06-24
Granted: 1997-05-07
Abstract: Une cuvette jetable (10) est moulée en une résine plastique transparente et rigide qui est imperméable aux liquides qu'elle est destinée à contenir. La cuvette (10) présente une section transversale rectangulaire. Des parois latérales identiques (45) s'étendent entre des extrémités supérieure et inférieure de chaque cuvette, l'extrémité supérieure étant ouverte de manière à permettre la réception des liquides et l'extrémité inférieure étant fermée. Des zones de surface optique en retrait (48, 50) à l'extrémité inférieure sont perpendiculaires l'une à l'autre et permettent la vérification optique du contenu de la cuvette. Une cartouche allongée (40) contient une pile de cuvettes adjacentes (10) de manière à en faciliter la manipulation.
Patent EP-0671083-B1 (EP)
Inventor: MUSZYNSKI PETER
IPC: H04J13/00
Filed: 1993-09-24
Granted: 1997-01-08
Abstract: Système et procédé de régulation de la qualité des signaux radioélectriques entre une pluralité de stations mobiles (MS) et une pluralité de stations fixes (BS) connectées à un central mobile (MSC) d'un système de télécommunications cellulaire à accès multiple par diférence de code (CDMA). Selon l'invention, chaque station fixe (BS) est conçue pour mesurer la qualité de chaque liaison CDMA active et pour signaler, pour chaque communication radiotéléphonique CDMA active, la qualité du signal de communication mesuré correspondant au central mobile (MSC). Ce dernier est agencé de façon à appliquer un processus de génération de moyenne auxdites valeurs de mesure de qualité signalées afin de calculer une valeur seuil de mesure de qualité recommandée. Les stations fixes (BS) sont agencées de façon à recevoir ladite valeur seuil recommandée afin de l'utiliser dans un algorithme de régulation de puissance à boucle fermée et à liaison ascendante pour lesdites stations mobiles (MS).
Patent EP-0660815-B1 (EP)
Inventor: KHAMBAY BHUPINDER PALL SINGH T
IPC: C07C43/29
Filed: 1993-09-16
Granted: 1997-04-16
Abstract: PCT No. PCT/GB93/01959 Sec. 371 Date Mar. 16, 1995 Sec. 102(e) Date Mar. 16, 1995 PCT Filed Sep. 16, 1993 PCT Pub. No. WO94/06741 PCT Pub. Date Mar. 31, 1994A pesticidal compound, suitable for combating soil borne insect pests has formula I:    <IMAGE>  (I)  in which formula: ArA represents a phenyl or naphthyl group optionally substituted by one or more groups selected from halogen, alkoxy, haloalkoxy, methylenedioxy, C1-C6 alkyl and C1-C6 haloalkyl; and ArB represents a phenoxy, phenyl, benzyl or benzoyl-substituted phenyl group which is optionally further substituted; the configuration of the aryl cyclopropyl group and the group CH2ArB about the double bond being mutually trans.
Patent EP-0667107-B1 (EP)
Inventor: ASANO TOSHIHIKO
IPC: A23L27/30
Filed: 1993-10-14
Granted: 2004-08-11
Abstract: A bifidobacterium growth promoter containing gluconic acid, a nontoxic salt thereof and/or glucono- delta -lactone as the active ingredient. It has not only a selective bifidobacterium growth promoter effect but also the effect of inhibiting the growth of deleterious bacteria. Further, it is reduced in the rate of digestion and absorption in the upper alimentary tract and hence has excellent characteristics as a bifidus factor. Therefore, this promoter can be used per se or as an additive for various food and drink to provide functional food and drink, thus being remarkably useful from the viewpoint of health improvement.
Patent EP-0655315-B1 (EP)
Inventor: ZUNDEL WERNER
IPC: B29C51/46
Filed: 1994-11-21
Granted: 1999-03-17
Abstract: By the invention it is intended to bring about a rapid build-up of the mould pressure for the compressed-air forming of an article made out of a thermoplastic sheet, without exceeding the predetermined value. This is achieved by installing a proportional valve, which feeds the forming air initially with the full cross-section and then, dependent on the forming pressure produced, constricts this cross-section shortly before reaching the forming pressure and closes it when the forming pressure is reached. The invention is represented characteristically by Figure 1. <IMAGE>
Patent EP-0611132-B1 (EP)
Inventor: BREGEN MICHAEL F
IPC: A61B17/08
Filed: 1994-02-08
Granted: 1997-01-08
Abstract: A self-closing receiverless surgical fastener (50) comprises a fastener body (51) of biocompatible or bioabsorbable material including a bridge member (52) and at least two tines (54) extending from opposite ends of the bridge member. The tines are resiliently deformable from a normally closed position with the distal ends (58) of the tines pointing toward each other to an open position with the distal ends of the tines extending substantially parallel to each other for penetrating into tissue. The tines (54) are resiliently returnable to the closed position with the distal ends (58) of the tines pointing toward each other to secure the fastener body (51) to the tissue.
Patent EP-0619289-B1 (EP)
Inventor: ZHANG JIAN JIAN
IPC: C07C49/88
Filed: 1994-03-25
Granted: 1998-05-13
Abstract: A process is disclosed for the synthesis of alkyl ketene dimers by the dehydrohalogenation of a C6 - C22 saturated or unsaturated linear fatty acid halide, comprising reacting the fatty acid chloride with a cyclic tertiary amine in an inert solvent at a temperature of up to 75 DEG , separating tertiary amine hydrochloride salts from alkyl ketene dimer dissolved in the solvent, and recovering the alkyl ketene dimer from the solvent.
Patent EP-0631810-B1 (EP)
Inventor: ALDRIDGE PAUL K
IPC: B01F29/60
Filed: 1994-06-03
Granted: 1997-09-10
Abstract: This invention relates to an apparatus for mixing compositions of matter into a homogeneous mixture and detecting on-line the homogeneity and potency of the mixture, and a method for using the same. More particularly, this invention relates to an apparatus for mixing the components of a pharmaceutical composition into a homogeneous mixture and detecting on-line the homogeneity and potency of said pharmaceutical composition. <IMAGE>
Patent EP-0730494-B1 (EP)
Inventor: NOTENBOMER ANNETTE
IPC: A23L27/40
Filed: 1993-11-25
Granted: 1998-02-04
Abstract: PCT No. PCT/NL93/00252 Sec. 371 Date May 28, 1996 Sec. 102(e) Date May 28, 1996 PCT Filed Nov. 25, 1993 PCT Pub. No. WO95/14531 PCT Pub. Date Jun. 1, 1995A method and particles for binding monovalent cations, each of the particles having a nucleus containing a cation exchange material, and applied thereon, a coating comprising a membrane being permeable for monovalent cations, in particular sodium, potassium, ammonium and hydrogen ions. The membrane is essentially not disintegrated during passage through the intestinal tract of humans or animals and wherein the membrane is more permeable for monovalent cations than for bi- or higher valent cations.
Patent EP-0679224-B1 (EP)
Title: Machine hydraulique et procede d'assemblage d'un piston et d'un patin a coulisse
Inventor: JEPSEN HARDY PETER
IPC: F04B1/12
Filed: 1993-12-23
Granted: 1997-10-22
Abstract: L'invention concerne une machine hydraulique présentant un piston et un organe à patin à coulisse, dans laquelle le piston (2) et le patin à coulisse (3) sont couplés l'un à l'autre par une articulation sphérique (4) formant une première surface de contact, le patin à coulisse (3) reposant, par l'intermédiaire d'une deuxième surface de contact, sur une surface de commande (9), et une couche réduisant la friction étant prévue sur une surface de contact. Ce type de machine hydraulique doit fonctionner, de préférence, de manière fiable même lorsqu'on utilise des fluides hydrauliques à faible pouvoir lubrifiant et voire nul, et bien que leur coût de fabrication soit faible. Dans cette optique, la couche réduisant la friction (11) est appliquée sur au moins une autre surface de contact.
Patent EP-0684911-B1 (EP)
Inventor: ARNAUD GEORGES
IPC: B60L11/18
Filed: 1994-01-28
Granted: 1997-03-26
Abstract: A drive system has at least one electric differential effect drive axle with two electric motors (M1, M2), one driving the right wheel and the other the left wheel. The current supplying the stator (ST2) of the second motor (M2) flows through the stator (ST1) of the first motor (M1). The current supplying the rotor (RO2) of the second motor (M2) flows through the rotor (RO1) of the first motor (M1). Control means (EP1, EP2) set the currents in the stators (ST1, ST2) and the rotors (RO1, RO2) according to information representing the angular position of said rotors (RO1, RO2). Application to motor vehicles.
Patent EP-0692963-B1 (EP)
Inventor: DE SIMONE CLAUDIO
IPC: A61K38/00
Filed: 1994-03-11
Granted: 2002-06-26
Abstract: PCT No. PCT/IT94/00023 Sec. 371 Date Sep. 12, 1995 Sec. 102(e) Date Sep. 12, 1995 PCT Filed Mar. 11, 1994 PCT Pub. No. WO94/20082 PCT Pub. Date Sep. 15, 1994A method of use comprising administering terbinafine for the primary and secondary prophylaxis and treatment of Pneumocystis carinii pneumonia, including oral administration of terbinafine at does of 3 to 20 mg/kg/day, to a subject suffering from this type of pneumonia is disclosed.
Patent EP-0642323-B1 (EP)
Inventor: PENNIG DIETMAR DR MED
IPC: A61B17/86
Filed: 1994-03-19
Granted: 1999-03-03
Abstract: A fixing pin (1) for securing small bone fragments (B) on larger bone fragments (A) during osteosynthesis operations has a smooth-walled shaft (2) connected to a threaded part (3). The transition zone (4) between the shaft and the threaded part is conically designed. In addition, a support washer (5) may be coupled to the fixing pin. The conical step of the fixing pin is engaged in a mating recess (6) of the support washer and the support washer is slightly concave.
Patent EP-0692028-B1 (EP)
Inventor: CAMPO MARIA SEVERIA
IPC: A61K38/45
Filed: 1994-03-31
Granted: 2003-06-04
Abstract: PCT No. PCT/GB94/00683 Sec. 371 Date Jan. 24, 1996 Sec. 102(e) Date Jan. 24, 1996 PCT Filed Mar. 31, 1994 PCT Pub. No. WO94/23037 PCT Pub. Date Oct. 13, 1994The invention provides pharmaceutical formulations for Immunizing against papillomavirus tumors or lesions. Formulations may be selected from the group consisting of: (i) a formulation which comprises a papillomavirus (PV) L2 protein or fragment thereof that is effective to provide a protective effect to lessen the occurrence and severity of lesions or tumors caused by PV infection and an aluminum compound; (ii) a formulation which comprises a bovine papillomavirus (BPV) L2 protein or said fragment thereof and an aluminum compound: (iii) a formulation which comprises a BPV4 L2 protein or said fragment thereof and an aluminum compound; (iv) a formulation which comprises a BPV-4 protein or said fragment thereof and an adjuvant; (v) a formulation which comprises a BPV-4 L2 protein or said fragment thereof and an adjuvant; and (vi) a formulation which comprises a BPV4 protein or said fragment thereof and an aluminum compound.
Patent EP-0725674-B1 (EP)
Title: Procede et dispositif permettant d'introduire des constituants d'un ciment pour les os dans un recipient ou ils doivent etre melanges
Inventor: JONSSON SOEREN
IPC: A61F2/00
Filed: 1994-05-06
Granted: 1997-09-10
Abstract: L'invention concerne un procédé et un dispositif permettant d'introduire, successivement, des doses de composants dans un récipient de mélange (2) sous vide partiel, utilisé pour préparer un ciment pour les os. Le dispositif (1) comprend, d'une part, un récipient intérieur (9) communiquant avec l'atmosphère et avec le récipient de mélange (2), ledit récipient (9) renfermant une ampoule de verre (11) contenant un composant liquide (A) de ciment pour les os, et, d'autre part, un dispositif (13a) servant à ouvrir l'ampoule (11) de sorte que son contenu, sous l'effet du vide partiel régnant dans le récipient de mélange (2), soit aspiré vers le bas et entre dans celui-ci. Un récipient extérieur (10) renferme le récipient intérieur (9) au moins partiellement et communique avec le récipient de mélange (2). Avec le récipient intérieur (9), le récipient extérieur (10) définit un espace (15) rempli d'une certaine quantité d'un second composant (B) de ciment pour les os, lequel composant se présente sous la forme d'une poudre. Le récipient intérieur (9) peut se déplacer par rapport au récipient extérieur (10) entre une première position, position dans laquelle des sections du récipient intérieur empêchent la communication entre le récipient de mélange (2) et l'atmosphère, et une seconde position, position dans laquelle le récipient de mélange (2) est en communication avec l'atmosphère, de sorte que le composant (B) de ciment pour les os, se présentant sous forme de poudre, puisse, sous l'effet du vide partiel régnant dans le récipient de mélange (2), être aspiré vers le bas et entrer dans celui-ci. L'introduction dans le récipient de mélange des composants (A, B) du ciment pour les os peut se faire dans n'importe quel ordre.
Patent EP-0705099-B1 (EP)
Inventor: LAURENT PHILIPPE
IPC: A61P11/00
Filed: 1994-06-14
Granted: 2001-10-24
Abstract: PCT No. PCT/FR94/00711 Sec. 371 Date Apr. 30, 1996 Sec. 102(e) Date Apr. 30, 1996 PCT Filed Jun. 14, 1994 PCT Pub. No. WO95/00132 PCT Pub. Date Jan. 5, 1995The present invention relates to the utilization of modafinil for the treatment of ventilation disorders of central origin such as sleep apnea.
Patent EP-0712496-B1 (EP)
Title: Quantification, par hplc, de transferrine pauvre en hydrate de carbone, destinee a la detection d'une consommation d'alcool elevee
Inventor: JEPPSSON JAN OLOF
IPC: G01N30/02
Filed: 1994-07-11
Granted: 2000-04-05
Abstract: Procédé de séparation et de quantification de transferrine pauvre en hydrate de carbone (CDT), permettant de déterminer la consommation d'alcool récente d'une personne. Des lipoprotéines sont précipitées dans du sérum sanguin et saturées avec du fer, après quoi l'échantillon est centrifugé après une courte période de stockage. La substance surnageante du mélange centrifugé est ensuite diluée avec de l'eau. Le mélange est ensuite injecté dans une colonne d'échange d'ions, et un gradient salin est utilisé pour la séparation des isoformes de transferrine. Un chromatogramme est développé par chromatographie liquide haute performance (HPLC) et un filtre permettant l'absorbance à 460 nm. Si le profil chromatographique indique des valeurs accrues de CDT (*, **), notamment une valeur dépassant 0,8 % de transférrine totale, il agit comme un indicateur à spécificité élevée d'une forte consommation d'alcool.
Patent EP-0711360-B1 (EP)
Title: Process for the identification of microorganisms using at least two chromogens
Inventor: RAMBACH ALAIN
IPC: C12R1/72
Filed: 1994-07-28
Granted: 1998-03-11
Abstract: PCT No. PCT/FR94/00958 Sec. 371 Date Jan. 26, 1996 Sec. 102(e) Date Jan. 26, 1996 PCT Filed Jul. 28, 1994 PCT Pub. No. WO95/04157 PCT Pub. Date Feb. 9, 1995A method for revealing the presence or absence of a particular microorganism strain in a culture medium, wherein at least two strain enzyme substrate chromogens are added to the culture medium, said chromogens being selected so that the presence of said strain in the culture medium is revealed by a third color.
Patent EP-0708951-B1 (EP)
Title: Systeme ameliore d'appel de patient/infirmiere
Inventor: NOVAK JOSEPH H
IPC: G08B25/08
Filed: 1994-07-12
Granted: 2000-09-20
Abstract: Un système (10) amélioré d'appel de patient/infirmière pour hôpital comprend des postes 'patient' (18) capables de générer des appels de l'hôpital, et une station maîtresse distante (32) qui établit l'ordre de priorité des appels et les enregistre. Les unités de vestibule, donc situées en dehors des chambres de patient (28), identifient les chambres (14) d'où proviennent les appels et le type d'appel. Chaque poste 'patient' (18) permet une recherche et l'affichage sélectifs des appels laissés sans réponse, et le système (10) permet en outre une interconnexion audio entre deux de ces postes (18, 32). Les badges (26) que portent les infirmières transmettent des signaux infrarouge à impulsions codées que reçoivent des récepteurs (121) aux stations 'patient' (18); le système (10) réagit en générant des signaux d'identité et d'emplacement qui sont enregistrés à la station maîtresse (32). L'information sur l'emplacement et l'identité de l'infirmière peut aussi être recherchée et affichée à tout poste 'patient' (18). La réception d'un signal infrarouge de l'infirmière (11) à une station maîtresse (18) annule automatiquement un appel de patient provenant de la chambre (14), ainsi que son affichage par l'unité de vestibule (28) et provoque en même temps un affichage (122) pour indiquer la présence de l'infirmière (11). Des unités de surveillance des lits (149) fonctionnent aussi en interconnexion avec les postes 'patient' (18) pour générer des signaux concernant l'état du lit.
Patent EP-0664452-B1 (EP)
Inventor: SLUKA DR PETER
IPC: C07F7/18
Filed: 1995-01-18
Granted: 2002-07-31
Abstract: A novel binding matrix (BM) consists of a carrier material (CM) having an oxide surface on which solid phase reactants (SPR) are covalently bonded via anchor gps. (AG). SPR can bond with one or more free reaction partners (FRP).  The novel features are that SPR form a dilute and laterally homogeneous binding layer on the surface of CM; and that AG are silane gps. linked with SPR via a spacer molecule. Silane cpds. of formulae (III) and (IV) are new: R1-R4 = substituents, where at least one of R1-R3 in (III) or at least one of R1-R4 in (IV) can form a covalent bond with an oxide surface; Sp = flexible, linear spacer molecule with a chain length of 2-50 atoms; X1-X3 = SPR or 1-4C alkoxy-oligo-2-4C alkylene oxide) (AOAO) gps., covalently bonded to Sp.  Also claimed are: (a) compartmented binding matrices (CBM), consisting of CM carrying several BM's (as described above) in spatially sepd. regions; (b) analytical elements consisting of BM or CBM covered with one or more additional layer(s) of reaction partners; (c) determn. of an analyte in a sample by a specific binding reaction between SPR and FRP, using BM or CBM as SPR; (d) a method for reducing non-specific protein binding to an oxide surface, by reacting the surface with (III) or (IV) where X1-X3 = AOAO gps.; and (e) articles with an oxide surface, where at least part of the surface is covered with a binder layer obtd. by reacting the surface with (III) or (IV) where X1-X3 = AOAO gps.
Patent EP-0667161-B1 (EP)
Inventor: CIMBOLLEK MONIKA DR
IPC: A61K9/00
Filed: 1995-01-26
Granted: 1999-03-17
Abstract: A depot formulation contg. clindamycin palmitate is claimed. Pref. implants contain 5-250 mg. clindamycin palmitate per cubic cm. Examples of typical implants are bone replacements, heart valves and sutures for these and artificial blood vessels.
Patent EP-0675599-B1 (EP)
Inventor: HIRAYAMA TAKESHI
IPC: H01L27/04
Filed: 1995-03-30
Granted: 2003-05-21
Abstract: In a semiconductor integrated circuit device, a MOS transistor has a relatively high built-in threshold, and in operation, a substrate bias is applied to the MOS transistor so as to cause the MOS transistor to forcibly have a reduced threshold, so that the MOS transistor operates at a high speed with the reduced threshold. When noise is detected, application of the substrate bias is stopped so that the MOS transistor restores the relatively high built-in threshold, and simultaneously, the MOS transistor is put in a standby condition, so that a malfunction can be prevented with the relatively high built-in threshold. <IMAGE>
Patent EP-0697408-B1 (EP)
Inventor: JURASZYK HORST DR
IPC: C07D263/20
Filed: 1995-08-10
Granted: 2002-01-23
Abstract: 2-Oxo-3-phenyl-oxazolidine-5-carboxylic acid derivs. of formula (I) and their isomers, salts and solvates are new:R1 = NO2, NR6R7, etc., or CH2NHCONH-Ph-E or D; X = OH, OA, AA, AA-AA' or a gp. of formula (X1)-(X3): E = e.g. CN; Y = CH2, CHOR5 or CO; R2 = H, A, Ar, etc.; R3 = (CH2)mCOOR5; R4 = (CH2)pCOOR5 or (CH2)qO(CH2)rCOOR5; AA,AA' = opt. protected amino acid residues selected from e.g. Ala,  beta -Ala, Arg, etc.;R5-R7 = H or A; m = 1-3; n = 1-4; p = 0-2; q = 0 or 1; r = 1 or 2; A = 1-6C alkylene; Ar = phenyl or benzyl; Ph- = phenylene.
Patent EP-0662457-B1 (EP)
Inventor: LOWE MARTIN
IPC: C03C17/42
Filed: 1995-01-09
Granted: 2000-05-03
Abstract: A method of producing heatable mirrors comprising depositing onto a ribbon of hot glass (1) during the production process a reflecting coating (2) whereby the mirrors so formed have a visible light reflection of at least 70% and depositing an electroconductive heating layer (7) onto the mirrors. The present invention also provides a heatable mirror comprising a glass substrate carrying a non-metallic reflecting coating whereby the mirror has a visible light reflection of at least 70% and an electroconductive heating layer deposited on the coated substrate. <IMAGE>
Patent EP-0670256-B1 (EP)
Inventor: LE GLOAN ANDRE
IPC: B60G21/055
Filed: 1995-02-27
Granted: 1996-05-01
Abstract: The trolley comprises a chassis (1) with several wheels (2,3), one of which, the driving and steering wheel (2), is situated in the longitudinal median plane of the trolley. Two directional stabiliser wheels (3A,3B) are located on either side of the steering wheel. Each stabiliser wheel is pivoted about a vertical axle and is movable in the vertical direction relative to the chassis. A spring (16) acts on these wheels through a mechanism (18,21,23,24) comprising two levers (23) connected by an anti-roll bar (24) which transmit a vertical force to the bottom of the stabiliser wheels. The mechanism is not attached to the stabiliser wheels but is supported by simple contact on the respective wheel pivots (9). The mechanism is thus free to separate from the mountings in a direction opposite to the spring action. A pin (15) penetrating a groove (14) in the pivot limits each wheel displacement towards the bottom of the chassis.
Patent EP-0741620-B1 (EP)
Inventor: PLESCHIUTSCHNIGG FRITZ-PETER
IPC: B22D11/04
Filed: 1995-01-20
Granted: 2001-02-21
Abstract: PCT No. PCT/DE95/00094 Sec. 371 Date Jul. 29, 1996 Sec. 102(e) Date Jul. 29, 1996 PCT Filed Jan. 20, 1995 PCT Pub. No. WO95/20448 PCT Pub. Date Aug. 3, 1995A continuous casting having a mold for producing strands in the form of slabs, thin slabs, blooms, and billets which results in a central running of the strand in the entire strand guide and in highly reliable casting at casting speeds of up to 6m/min. As a result of the cambered, concave shape of the mold and entire strand guide, the strand is guided coaxially to the entire strand guide from the cast surface until the strand exits at the delivery end of the continuous casting machine so that sideways movement of the entire strand in the direction of one of the narrow sides (snaking) is suppressed. This symmetrical running of the strand shell box to the mold and of the rest of the strand to the strand roll-guide results in a uniform symmetrical formation of the strand shell and its temperature field (isotherms), the withdrawal forces, and the loading of the strand shell in the region of the mold and the rest of the strand guide while at the same time ensuring that the strand runs centrally with reference to the center axis in the direction of the strand axes.